next generation glp-1 therapies evolving to multi-hormone action | Mahesh Malhotra posted on the topic Next-Gen GLP-1 after Ozempic: Retatrutide

Describes studies on GLP-1 medication users, not specific product claims

On current evidence, effective weight management should be provided to all people with type 2 diabetes as soon as possible after diagnosis (or even earlier, at the stage of prediabetes, defined in Europe, Australasia, Canada [and most of the world] as 42 and 10 kg and remission lasting 12 years may also delay vascular complications, although more evidence is needed

If youve been searching for asafe, effective, and sustainableway to lose weight,Tirzepatidemight be your breakthrough

Learn how Ozempic, Wegovy, and similar drugs may affect SIBO, IMO, IBS symptoms, and the gut microbiome.

Strengths Strong traditional use and modern clinical support Potential to support both gut hormone and pancreatic gene activity Generally safe in moderate doses Limitations Wide dose range in studies, optimal dosing unclear Potentiate the effects of other glucose-lowering agents Safety Precautions and Limitations of GLP-1 Supporting Botanicals Even though these botanicals may gently support the bodys GLP-1 pathways, they are not stand-alone therapies and should be used thoughtfully. Because many of these compounds affect insulin secretion or glucose uptake, combining them with pharmaceuticals can raise the risk of hypoglycemia